AFP (Alpha-Fetoprotein): Normal Range, Results & What They Mean

What is Alpha-Fetoprotein (AFP)?

Alpha-fetoprotein (AFP) is a protein produced primarily by the fetal liver and yolk sac during development. In healthy adults, AFP levels are very low. However, AFP can become elevated in certain cancers and during pregnancy.

Think of AFP as a protein that should be "turned off" after birth. When it reappears in significant amounts during adulthood, it can signal that something is wrong—most commonly liver disease or certain cancers.

Understanding Your Results

AFP is measured in nanograms per milliliter (ng/mL). Normal levels are very low in healthy adults:

What Causes Elevated AFP?

Several conditions can raise AFP levels:

When is AFP Testing Used?

Doctors use AFP testing in several specific situations:

1. Hepatocellular carcinoma (HCC) screening:

• People with chronic hepatitis B or C
• People with cirrhosis from any cause
• Regular AFP and ultrasound surveillance (every 6 months)
• Early detection improves treatment outcomes

2. Diagnosing liver cancer:

• Elevated AFP + liver mass on imaging = highly likely HCC
• AFP ＞400 ng/mL is considered diagnostic for HCC in at-risk patients
• Used in combination with imaging (CT, MRI)

3. Monitoring treatment response:

• AFP levels should fall with successful HCC treatment
• Rising AFP after treatment suggests recurrence
• More sensitive than imaging for detecting early recurrence

4. Germ cell tumors:

• Testicular cancer diagnosis and staging
• Monitoring treatment response
• Detecting recurrence
• Often combined with hCG testing

5. Prenatal screening:

• Neural tube defects (spina bifida, anencephaly) cause HIGH AFP
• Down syndrome causes LOW AFP
• Typically performed at 15-20 weeks gestation

AFP in Liver Cancer

Hepatocellular carcinoma (HCC) is the most common reason for significantly elevated AFP in adults:

AFP levels and HCC diagnosis:

• AFP ＞400 ng/mL in at-risk patient + liver mass = diagnostic for HCC
• No biopsy needed when these criteria are met
• Lower AFP levels require biopsy for definitive diagnosis

AFP for HCC prognosis:

• Higher AFP correlates with worse prognosis
• AFP ＞1,000 ng/mL suggests advanced disease
• Normal AFP after treatment indicates better outcome

AFP for HCC monitoring:

• Check every 3 months during active treatment
• Rising AFP typically precedes radiographic recurrence by 2-6 months
• Allows earlier intervention for recurrence

AFP in Germ Cell Tumors

AFP is one of the most important tumor markers for germ cell tumors:

Testicular cancer:

• Elevated in 50-70% of non-seminomatous germ cell tumors
• Normal in pure seminomas
• Combined with hCG for diagnosis and staging
• Used to monitor treatment response and detect recurrence

Ovarian germ cell tumors:

• Yolk sac tumors produce very high AFP
• Other germ cell tumors may also elevate AFP
• Important for diagnosis and monitoring

Prognostic significance:

• AFP levels help classify tumor stage and prognosis
• Higher AFP = higher tumor burden in most cases
• Normalization of AFP with treatment = good prognosis

Your Action Plan Based on Results

If your AFP is normal (＜10 ng/mL):

• No evidence of AFP-producing tumors
• In at-risk patients, continue regular surveillance
• No specific action needed based on AFP alone

If your AFP is mildly elevated (10-50 ng/mL):

• Often due to benign liver disease
• Context matters—risk factors, symptoms, liver function tests
• May need repeat testing to check trend
• Imaging may be recommended if liver disease present

If your AFP is moderately elevated (50-200 ng/mL):

• Suspicious for malignancy
• Requires investigation
• Liver imaging (ultrasound, CT, MRI) typically recommended
• If testicular mass present: evaluate for germ cell tumor
• Specialist referral often appropriate

If your AFP is very high (＞200-400 ng/mL):

• Strongly suggests cancer
• Urgent evaluation needed
• Comprehensive imaging to locate tumor
• Specialist referral (oncology, hepatology)
• Tissue biopsy for definitive diagnosis

Special Considerations

Pregnancy:

• AFP is normally elevated during pregnancy
• Produced by fetal liver
• Peaks at 12-14 weeks, then declines
• Used for prenatal screening, not cancer detection
• Completely different context than adult AFP testing

False positives:

• AFP can be elevated in benign liver disease
• Not every elevated AFP means cancer
• Clinical correlation and imaging essential
• Trends are more informative than single values

AFP-negative HCC:

• 10-30% of HCCs don't produce AFP
• Normal AFP doesn't rule out liver cancer in at-risk patients
• Imaging surveillance still essential
• This is why ultrasound is always combined with AFP

Limitations of AFP Testing

AFP has important limitations as a cancer test:

Sensitivity issues:

• Not all liver cancers produce AFP
• Early stage HCC may have normal AFP
• Small tumors may not elevate AFP significantly

Specificity issues:

• Benign liver disease can elevate AFP
• Hepatitis flare can cause significant AFP elevation
• Liver regeneration after injury produces AFP

Not a screening test for general population:

• Too many false positives in average-risk people
• Not cost-effective for population screening
• Best used in high-risk groups

Common Questions

---

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider to interpret your lab results and determine the appropriate next steps. Reference ranges may vary between laboratories—always use the ranges provided on your lab report.